Guiding treatment decisions in early breast cancer: A model-based comparison of the OncotypeDX and MammaPrint tests
{{output}}
Introduction: Genomic tests may improve chemotherapy allocation in early-stage breast cancer beyond traditional clinical factors. We compared the clinical usefulness of two multi-genomic tests, MammaPrint and OncotypeDX, in guidi... ...
